Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
Sponsor: Indiana University
Summary
This study is an RCT to evaluate the effectiveness of Brain Safe on reducing anticholinergic exposure. Over 42 months, the trial will enroll 700 community-dwelling older adults who were prescribed one or more strong anticholinergics. Participants will be randomized to use the Brain Safe app or an attention control medication list app for 12 months, with monthly usage reminders.
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
706
Start Date
2019-10-16
Completion Date
2025-02-27
Last Updated
2026-07-20
Healthy Volunteers
No
Conditions
Interventions
Brain Safe App
The Brain Safe app includes the medication list, a personalized risk calculator, multimedia educational content, and a conversation starter/doctor's report.
Attention Control App
The attention control app, called Med Safe, includes only the medication list feature.
Locations (2)
Indiana University
Indianapolis, Indiana, United States
IU Health
Indianapolis, Indiana, United States